Healthcare and Life Science
Strategies for coping with ILD
Interstitial lung disease (ILD) is a chronic and life-limiting lung disease with no curative options which can take a significant emotional toll on sufferers. A diagnosis of ILD comes with feelings of anxiety and uncertainty about the future. As the condition progresses, patients are al...
evitria Partners with Sapio Sciences to streamline antibody workflow management and reporting
Leading antibody expression service provider implements Sapio’s ELN and Report Builder for advanced sample tracking and data management ...
Orbit Discovery and Evergreen Theragnostics expand research collaboration to advance targeted therapeutics development
Oxford, UK, and Springfield, NJ, USA, 3rd December 2024: Orbit Discovery, a leading provider of peptide discovery services, and Evergreen Theragnostics, a radiopharmaceutical company at the forefront of precision medicine, today announced an extension to their research collaboration to ...
Case Study: Thames Valley and Surrey Secure Data Environment
The Thames Valley and Surrey Secure Data Environment (SDE) case study highlights the collaboration between NHS and System C to enhance data security and accessibility. The SDE integrates data from multiple sources, providing a secure platform for health and care professionals to access ...
Drive business success with Best Employers Eastern Region 2025
Best Employers has been changing the face of employee engagement since 2012, by helping organisations get a deeper understanding of their employees through a detailed engagement survey. Personalised results and tailored action plans then help them evolve their workplaces for the better....
Targeting IL-23, Medicilon assists the development of a variety of new drugs for Psoriasis
With people’s in-depth understanding of the inflammatory pathways of psoriasis, biologics continue to develop. From tumor necrosis factor alpha (TNF-α), to IL-17 inhibitors, and then to IL-23 inhibitors, biologics have brought new light to the treatment of psoriasis again. In recent y...
Medicilon neural system disease models help our clients advance novel drug development
Medicilon Pharmacodynamics Department can deliver multiple nervous system models based on anti-depressants, anti-Alzheimer's drugs, sedative-hypnotic and anti-anxiety drugs, analgesics, anti-convulsant, anti-Parkinson's drugs, and anti-schizophrenia drugs. Those models can effectively e...
Centauri Therapeutics awarded £1M grant under new PACE programme to advance immunotherapy platform in anti-infectives
Funding to support further development of lead programme for a novel therapeutic targeting Gram-negative bacteria including Multi-Drug-Resistant strains Optimisation will also support application of the Alphamer® platform across other therapeutic indications, including oncologyLond...
Metrion Biosciences appoints Lee Patterson as CEO
Significant CRO C-suite experience expected to drive growth and commercial expansion into global marketsCambridge, UK, 25 November 2024: Metrion Biosciences, the specialist preclinical contract research organisation (CRO) and a leader in ion channel screening, announces the appoint...
Guardtech Group hoping to end golden year with more success at SME National Business Awards
Suffolk contamination control experts looking to add Best Enterprising Business prize to epic 2024 awards haul at glitzy Wembley Stadium showpiece on 6 December ...